Chinese researchers have developed and externally validated a prediction model combining PSA, tumor stage, biopsy grade, and ...

Prostate cancer cases are rising in India, but advances in diagnostics, targeted therapies and personalised treatment are ...

A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of ...

Reprinted from the email newsletter issued on September 30, 2026They say autumn is the season of long rains, and September in ...

Clarity Pharmaceuticals reaches its recruitment target in the main SECuRE expansion group as radiopharmaceutical programs advance.

The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...

Applied to samples from more than 600 patients and controls, urinary cell-free RNA profiling with uRARE-seq demonstrated high sensitivity in detecting bladder cancer, and correlated with treatment ...

The Canadian Urological Association (CUA) has published a multidisciplinary expert report offering Canadian consensus recommendations on prostate-specific membrane antigen (PSMA) positron emission ...

A new theranostics suite is streamlining treatment and clinical trials for certain types of cancer, notably prostate cancer ...

Despite more than a half century behind the wheel plus a spate of medical issues, owner-driver Ken Wilkie is keeping the ...